While decentralized clinical trials offer several benefits, their implementation is not without hurdles.
These challenges often stem from the complexity of coordinating technology, regulatory compliance, and patient needs.
Some of the main challenges include:
1. Data Privacy and Security
With patient data collected remotely and digitally,
robust cybersecurity measures are critical to protecting sensitive health information.
2. Technology Access and Literacy
Not all patients may have access to or familiarity with the required digital tools, creating potential barriers to participation.
3. Regulatory Hurdles
Decentralized trials require the support of regulatory agencies to ensure that
remote data collection methods comply with standards across different regions; as of now, consistent global guidelines are still in development.
Despite these challenges, decentralized trials present significant opportunities for innovation in
clinical research.
With sponsors’ increasing investment in DCT infrastructures and the regulatory landscape’s ongoing evolution, the adoption of DCTs is anticipated to gain momentum, poised to develop more
patient-centric trial designs.